NCT07085429 Development of Clinical and Biological Database on Bronchial Cancer
| NCT ID | NCT07085429 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 750 participants |
| Start Date | 2025-11-25 |
| Primary Completion | 2030-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 750 participants in total. It began in 2025-11-25 with a primary completion date of 2030-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical data to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to bronchial cancer.
Eligibility Criteria
Inclusion Criteria: * Male or female patient aged over 18 years, * Histologically or cytologically confirmed bronchial cancer, * Treatment-naïve patient for the current cancer, * Patient who has provided informed, written, and explicit consent, * Patient affiliated with the French national health insurance system. Exclusion Criteria: * Patient with a WHO performance status ≥ 3, * Pregnant and/or breastfeeding woman, * Patient with a history of other cancers within the 5 years preceding inclusion, * Patient for whom regular follow-up is considered impossible due to psychological, familial, social, or geographic reasons, * Patient under legal protection (guardianship, curatorship, or judicial protection).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07085429 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07085429 currently recruiting?
Yes, NCT07085429 is actively recruiting participants. Contact the research team at emmanuelle.texier@icm.unicancer.fr for enrollment information.
Where is the NCT07085429 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT07085429 clinical trial?
NCT07085429 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. The trial plans to enroll 750 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.